Genetic Testing to Optimize Cardiovascular Disease Treatment and Outcomes

Warfarin, Plavix sensitivity tests and thrombophilia risk test provide personalized risk assessment, diagnosis and treatment

 

September 13, 2013

Atherotech Diagnostics Lab offers warfarin sensitivity, Plavix sensitivity and thrombophilia risk tests.

The warfarin and Plavix sensitivity tests look for genetic variation in how patients metabolize these life-saving, anti-blood clotting drugs. This helps physicians determine the right dose or consider a medication change to help prevent blood clots that can lead to a heart attack or stroke.

The thrombophilia risk test looks for specific gene mutations (Factor II, Factor V and MTHFR mutations) in patients with suspected thrombophilia. These mutations significantly increase the risk of developing a blood clot, potentially leading to a heart attack or stroke. It is primarily used for patients with a personal or family history of blood clots.

For more information: www.atherotech.com